Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. That said, here are three stocks where Wall Street may be overlooking some important risks and some alternatives with better fundamentals.

BILL (BILL)

Consensus Price Target: $62.09 (33.1% implied return)

Transforming the messy back-office financial operations that plague small business owners, BILL (NYSE: BILL) provides a cloud-based platform that automates accounts payable, accounts receivable, and expense management for small and midsize businesses.

Why Does BILL Worry Us?

1. Customers had second thoughts about committing to its platform over the last year as its average billings growth of 11.9% underwhelmed
2. Estimated sales growth of 10.5% for the next 12 months implies demand will slow from its two-year trend
3. Operating margin improvement of 3.1 percentage points over the last year demonstrates its ability to scale efficiently

At $46.65 per share, BILL trades at 3x forward price-to-sales. To fully understand why you should be careful with BILL, check out our full research report (it’s free).

E.W. Scripps (SSP)

Consensus Price Target: $5.63 (56.3% implied return)

Founded as a chain of daily newspapers, E.W. Scripps (NASDAQ: SSP) is a diversified media enterprise operating a range of local television stations, national networks, and digital media platforms.

Why Is SSP Risky?

1. Muted 6.5% annual revenue growth over the last five years shows its demand lagged behind its consumer discretionary peers
2. Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned
3. 5× net-debt-to-EBITDA ratio makes lenders less willing to extend additional capital, potentially necessitating dilutive equity offerings

E.W. Scripps is trading at $3.60 per share, or 7.8x forward EV-to-EBITDA. Check out our free in-depth research report to learn more about why SSP doesn’t pass our bar.

Allstate (ALL)

Consensus Price Target: $236.29 (22.9% implied return)

Born from a Sears, Roebuck & Co. initiative during the Great Depression with its famous "You're in good hands" slogan, Allstate (NYSE: ALL) is one of America's largest personal property and casualty insurers, offering protection for autos, homes, and personal property.

Why Are We Cautious About ALL?

1. Estimated sales growth of 1.4% for the next 12 months implies demand will slow from its two-year trend
2. Static combined ratio over the last five years shows it couldn’t improve its operations
3. Scale is a double-edged sword because it limits the firm’s capital growth potential compared to its smaller competitors, as reflected in its below-average annual book value per share increases of 3.2% for the last five years

Allstate’s stock price of $192.20 implies a valuation ratio of 1.9x forward P/B. Dive into our free research report to see why there are better opportunities than ALL.

Stocks We Like More

Check out the high-quality names we’ve flagged in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.